Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Thalidomide for Chronic Discoid Lupus Erythematosus
NCT00001680Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in discoid lupus erythematosus (DLE), sponsored by National Cancer Institute. Started Oct 1997; status: completed.
02
Drugs
thalidomide
03
Conditions
discoid lupus erythematosus (DLE)
Beyond the preview
Go deeper on NCT00001680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001680.